All Relations between glp-1 and insulin

Publication Sentence Publish Date Extraction Date Species
Tingxu Yan, Tingting Nian, Fuyuan Li, Bosai He, Ying Jia, Kaishun Bi, Zhenzhong Wan. Salidroside from Rhodiola wallichiana var. cholaensis reverses insulin resistance and stimulates the GLP-1 secretion by alleviating ROS-mediated activation of MAPKs signaling pathway and mitigating apoptosis. Journal of food biochemistry. vol 44. issue 11. 2021-05-26. PMID:32910486. our data demonstrated that sal could reverse insulin resistance and stimulates the glp-1 secretion by alleviating ros-mediated activation of mapks signaling pathway and mitigating apoptosis. 2021-05-26 2023-08-13 Not clear
Emma Rose McGlone, Khalefah Malallah, Joyceline Cuenco, Nicolai J Wewer Albrechtsen, Jens J Holst, Royce P Vincent, Charlotte Ling, Omar A Khan, Surabhi Verma, Ahmed R Ahmed, Julian R F Walters, Bernard Khoo, Stephen R Bloom, Tricia M M Ta. Differential effects of bile acids on the postprandial secretion of gut hormones: a randomized crossover study. American journal of physiology. Endocrinology and metabolism. vol 320. issue 4. 2021-05-24. PMID:33459181. glucose, insulin, glp-1, oxm, pyy, gip, glucagon, ghrelin, and fibroblast growth factor 19 were measured prior to ba administration at -60 and 0 min (just prior to mixed meal) and 15, 30, 60, 120, 180, and 240 min after the meal. 2021-05-24 2023-08-13 human
Emma Rose McGlone, Khalefah Malallah, Joyceline Cuenco, Nicolai J Wewer Albrechtsen, Jens J Holst, Royce P Vincent, Charlotte Ling, Omar A Khan, Surabhi Verma, Ahmed R Ahmed, Julian R F Walters, Bernard Khoo, Stephen R Bloom, Tricia M M Ta. Differential effects of bile acids on the postprandial secretion of gut hormones: a randomized crossover study. American journal of physiology. Endocrinology and metabolism. vol 320. issue 4. 2021-05-24. PMID:33459181. cdca increased fasting glp-1 and oxm secretion in parallel with an increase in insulin. 2021-05-24 2023-08-13 human
Emmanouil Korakas, Aikaterini Kountouri, Athanasios Raptis, Alexander Kokkinos, Vaia Lambadiar. Bariatric Surgery and Type 1 Diabetes: Unanswered Questions. Frontiers in endocrinology. vol 11. 2021-05-21. PMID:33071965. the reasons for these results are yet to be elucidated; possible explanations include preservation of beta cell mass and increased residual function post-surgery, improvement in insulin action, altered glp-1 function, timing of surgery, and association with residual islet cell mass. 2021-05-21 2023-08-13 Not clear
Barrie Chubb, Palvi Gupta, Jatin Gupta, Solomon Nuhoho, Klaus Kallenbach, Michelle Orm. Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders. vol 12. issue 5. 2021-05-21. PMID:33723769. once-daily oral semaglutide versus injectable glp-1 ras in people with type 2 diabetes inadequately controlled on basal insulin: systematic review and network meta-analysis. 2021-05-21 2023-08-13 human
Barrie Chubb, Palvi Gupta, Jatin Gupta, Solomon Nuhoho, Klaus Kallenbach, Michelle Orm. Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis. Diabetes therapy : research, treatment and education of diabetes and related disorders. vol 12. issue 5. 2021-05-21. PMID:33723769. the relative efficacy and safety of once-daily oral semaglutide vs. injectable glucagon-like peptide-1 receptor agonists (glp-1 ras) in subjects with type 2 diabetes (t2d) inadequately controlled on basal insulin were assessed using network meta-analysis (nma). 2021-05-21 2023-08-13 human
Ben Jone. The therapeutic potential of GLP-1 receptor biased agonism. British journal of pharmacology. 2021-05-21. PMID:33880754. glucagon-like peptide-1 (glp-1) receptor agonists are effective treatments for type 2 diabetes as they stimulate insulin release and promote weight loss through appetite suppression. 2021-05-21 2023-08-13 human
Jana Pavlisova, Olga Horakova, Veronika Kalendova, Jana Buresova, Kristina Bardova, Blanka Holendova, Lydie Plecita-Hlavata, Sarka Vackova, Jindra Windrichova, Ondrej Topolcan, Jan Kopecky, Martin Rossmeis. Chronic n-3 fatty acid intake enhances insulin response to oral glucose and elevates GLP-1 in high-fat diet-fed obese mice. Food & function. vol 11. issue 11. 2021-05-18. PMID:33078809. chronic n-3 fatty acid intake enhances insulin response to oral glucose and elevates glp-1 in high-fat diet-fed obese mice. 2021-05-18 2023-08-13 mouse
Jana Pavlisova, Olga Horakova, Veronika Kalendova, Jana Buresova, Kristina Bardova, Blanka Holendova, Lydie Plecita-Hlavata, Sarka Vackova, Jindra Windrichova, Ondrej Topolcan, Jan Kopecky, Martin Rossmeis. Chronic n-3 fatty acid intake enhances insulin response to oral glucose and elevates GLP-1 in high-fat diet-fed obese mice. Food & function. vol 11. issue 11. 2021-05-18. PMID:33078809. in addition, these mice had improved glucose tolerance, which was consistent with an increased insulin response to oral glucose and plasma glucagon-like peptide-1 (glp-1) levels. 2021-05-18 2023-08-13 mouse
Atefeh Pegah, Ebrahim Abbasi-Oshaghi, Iraj Khodadadi, Fatemeh Mirzaei, Heidar Tayebina. Probiotic and resveratrol normalize GLP-1 levels and oxidative stress in the intestine of diabetic rats. Metabolism open. vol 10. 2021-05-18. PMID:33997755. one of the important incretins in the improvement of diabetes is glucagon-like peptide (glp-1), which is secreted by the gut and reduces the apoptosis of pancreatic β-cells and improves insulin sensitivity. 2021-05-18 2023-08-13 rat
Atefeh Pegah, Ebrahim Abbasi-Oshaghi, Iraj Khodadadi, Fatemeh Mirzaei, Heidar Tayebina. Probiotic and resveratrol normalize GLP-1 levels and oxidative stress in the intestine of diabetic rats. Metabolism open. vol 10. 2021-05-18. PMID:33997755. in this experiment we determined the effects of resveratrol and probiotics on insulin resistance, oxidative stress, and glp-1 in type 2 diabetes (t2d) rats. 2021-05-18 2023-08-13 rat
C J Tack, F A van de Laa. [Starting insulin or not? And if so, which basal insulin?] Nederlands tijdschrift voor geneeskunde. vol 164. 2021-05-17. PMID:33201616. our patient achieved reasonable glucose control without weight gain using a combination of basal insulin and a glp-1 receptor agonist. 2021-05-17 2023-08-13 Not clear
Florian Kahles, Marcia V Rückbeil, Robert W Mertens, Ann C Foldenauer, Maria C Arrivas, Julia Moellmann, Corinna Lebherz, Moritz Biener, Evangelos Giannitsis, Hugo A Katus, Nikolaus Marx, Michael Lehrk. Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction. European heart journal. vol 41. issue 7. 2021-05-14. PMID:31620788. glucagon-like peptide 1 (glp-1) is a gut incretin hormone inducing post-prandial insulin secretion. 2021-05-14 2023-08-13 Not clear
Kaitlin M Love, Jia Liu, Judith G Regensteiner, Jane E B Reusch, Zhenqi Li. GLP-1 and insulin regulation of skeletal and cardiac muscle microvascular perfusion in type 2 diabetes. Journal of diabetes. vol 12. issue 7. 2021-05-14. PMID:32274893. glp-1 and insulin regulation of skeletal and cardiac muscle microvascular perfusion in type 2 diabetes. 2021-05-14 2023-08-13 Not clear
Kaitlin M Love, Jia Liu, Judith G Regensteiner, Jane E B Reusch, Zhenqi Li. GLP-1 and insulin regulation of skeletal and cardiac muscle microvascular perfusion in type 2 diabetes. Journal of diabetes. vol 12. issue 7. 2021-05-14. PMID:32274893. thus, treatment of insulin resistant patients with glp-1 receptor agonists may improve skeletal and cardiac muscle microvascular perfusion and increase muscle capillarization, leading to improved delivery of oxygen, nutrients, and hormones such as insulin to the myocytes. 2021-05-14 2023-08-13 Not clear
Jing Huang, Yunhan Liu, Liusiyuan Cheng, Jihong Li, Tangrui Zhang, Gang Zhao, Huinan Zhan. Glucagon-like peptide-1 cleavage product GLP-1(9-36) reduces neuroinflammation from stroke via the activation of insulin-like growth factor 1 receptor in astrocytes. European journal of pharmacology. vol 887. 2021-05-14. PMID:32949596. glucagon-like peptide-1 (glp-1) is an endogenous gut hormone and a key regulator in maintaining glucose homeostasis by stimulating insulin secretion. 2021-05-14 2023-08-13 mouse
Shumin Jiang, Xueli Wu, Yi Wang, Jingtao Zou, Xiaoping Zha. The potential DPP-4 inhibitors from Xiao-Ke-An improve the glucolipid metabolism via the activation of AKT/GSK-3β pathway. European journal of pharmacology. vol 882. 2021-05-13. PMID:32535096. dipeptidyl peptidase-4 (dpp-4) is a specific enzyme hydrolyzing the incretin hormone glucagon like peptide-1 (glp-1) and glucose-dependent insulinotropic polypeptide (gip) to reduce insulin secretion, meanwhile dpp-4 inhibitors play an important role in diabetic therapy. 2021-05-13 2023-08-13 Not clear
Katarzyna Szkudelska, Marzanna Deniziak, Maciej Sassek, Ignacy Szkudelski, Wojciech Noskowiak, Tomasz Szkudelsk. Resveratrol Affects Insulin Signaling in Type 2 Diabetic Goto-Kakizaki Rats. International journal of molecular sciences. vol 22. issue 5. 2021-05-12. PMID:33671110. blood levels of insulin and gip were elevated, whereas proinsulin and glp-1 diminished in gk rats. 2021-05-12 2023-08-13 rat
Jinyu Wang, Xiaoying Zhang, Luxin Zhang, Tingxu Yan, Bo Wu, Fanxing Xu, Ying Ji. Silychristin A activates Nrf2-HO-1/SOD2 pathway to reduce apoptosis and improve GLP-1 production through upregulation of estrogen receptor α in GLUTag cells. European journal of pharmacology. vol 881. 2021-05-10. PMID:32497626. glucagon-like peptide-1 (glp-1), a glucagon-like peptide secreted mainly from intestinal l cells, possesses the functions of promoting synthesis and secretion of insulin in pancreatic β-cells, and maintaining glucose homeostasis in an insulin-independent manner. 2021-05-10 2023-08-13 rat
Yuta Fujiwara, Shunsuke Yamane, Norio Harada, Eri Ikeguchi-Ogura, Ryota Usui, Toshihiro Nakamura, Kanako Iwasaki, Kazuyo Suzuki, Daisuke Yabe, Yoshitaka Hayashi, Nobuya Inagak. Carbonic anhydrase 8 (CAR8) negatively regulates GLP-1 secretion from enteroendocrine cells in response to long-chain fatty acids. American journal of physiology. Gastrointestinal and liver physiology. vol 320. issue 4. 2021-05-10. PMID:33533304. glucagon-like peptide-1 (glp-1) is an incretin secreted from enteroendocrine preproglucagon (ppg)-expressing cells (traditionally known as l cells) in response to luminal nutrients that potentiates insulin secretion. 2021-05-10 2023-08-13 Not clear